©2024 Stanford Medicine
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini
Recruiting
Trial ID: NCT04183413
Purpose
The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the
population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary
care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and
hypertension was mostly provided through physician-led teams in hospital outpatient
departments. The healthcare reform aims to strengthen the provision of nurse-led care for
diabetes and hypertension in primary healthcare facilities and community health worker-led
care for these conditions in the facilities' catchment areas. The reform will broadly be
guided by the World Health Organization's "Package of Essential Noncommunicable Disease
Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will
take place at 84 clusters (a primary healthcare facility and its catchment area) across the
country.
Official Title
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini: A Cluster-randomized Trial
Stanford Investigator(s)
Eligibility
Inclusion criteria for the outcome assessment (household survey):
- Residing in one of the selected households
- Age ≥40 years
Exclusion criteria for the outcome assessment (household survey):
- Pregnant
- Inability to provide written informed consent
Intervention(s):
other: DSD
other: CDP
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305